Literature DB >> 29264430

Therapeutic strategies for wild-type gastrointestinal stromal tumor: is it different from KIT or PDGFRA-mutated GISTs?

Toshirou Nishida1.   

Abstract

Entities:  

Year:  2017        PMID： 29264430      PMCID： PMC5723739          DOI： 10.21037/tgh.2017.11.05

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  21 in total

Review 1.  Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.

Authors:  Sebastian Huss; Helen Pasternack; Michaela Angelika Ihle; Sabine Merkelbach-Bruse; Birthe Heitkötter; Wolfgang Hartmann; Marcel Trautmann; Heidrun Gevensleben; Reinhard Büttner; Hans-Ulrich Schildhaus; Eva Wardelmann
Journal:  Hum Pathol       Date:  2017-02-01       Impact factor: 3.466

2.  Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors: 
Journal:  Ann Oncol       Date:  2014-09       Impact factor: 32.976

3.  Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.

Authors:  Sosipatros A Boikos; Alberto S Pappo; J Keith Killian; Michael P LaQuaglia; Chris B Weldon; Suzanne George; Jonathan C Trent; Margaret von Mehren; Jennifer A Wright; Josh D Schiffman; Margarita Raygada; Karel Pacak; Paul S Meltzer; Markku M Miettinen; Constantine Stratakis; Katherine A Janeway; Lee J Helman
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

4.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 5.  Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

Authors:  Heikki Joensuu; Aki Vehtari; Jaakko Riihimäki; Toshirou Nishida; Sonja E Steigen; Peter Brabec; Lukas Plank; Bengt Nilsson; Claudia Cirilli; Chiara Braconi; Andrea Bordoni; Magnus K Magnusson; Zdenek Linke; Jozef Sufliarsky; Massimo Federico; Jon G Jonasson; Angelo Paolo Dei Tos; Piotr Rutkowski
Journal:  Lancet Oncol       Date:  2011-12-06       Impact factor: 41.316

6.  MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

Authors:  Walter J Jessen; Shyra J Miller; Edwin Jousma; Jianqiang Wu; Tilat A Rizvi; Meghan E Brundage; David Eaves; Brigitte Widemann; Mi-Ok Kim; Eva Dombi; Jessica Sabo; Atira Hardiman Dudley; Michiko Niwa-Kawakita; Grier P Page; Marco Giovannini; Bruce J Aronow; Timothy P Cripe; Nancy Ratner
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

7.  Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases.

Authors:  Jerzy Lasota; Anna Felisiak-Golabek; Bartosz Wasag; Artur Kowalik; Sebastian Zięba; Małgorzata Chłopek; Zeng-Feng Wang; Tiffany Coates; Janusz Kopczynski; Stanislaw Gozdz; Maarit Sarlomo-Rikala; Markku Miettinen
Journal:  Mod Pathol       Date:  2016-01-22       Impact factor: 7.842

8.  Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.

Authors:  J Keith Killian; Su Young Kim; Markku Miettinen; Carly Smith; Maria Merino; Maria Tsokos; Martha Quezado; William I Smith; Mona S Jahromi; Paraskevi Xekouki; Eva Szarek; Robert L Walker; Jerzy Lasota; Mark Raffeld; Brandy Klotzle; Zengfeng Wang; Laura Jones; Yuelin Zhu; Yonghong Wang; Joshua J Waterfall; Maureen J O'Sullivan; Marina Bibikova; Karel Pacak; Constantine Stratakis; Katherine A Janeway; Joshua D Schiffman; Jian-Bing Fan; Lee Helman; Paul S Meltzer
Journal:  Cancer Discov       Date:  2013-04-02       Impact factor: 39.397

Review 9.  The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.

Authors:  Toshirou Nishida; Jean-Yves Blay; Seiichi Hirota; Yuko Kitagawa; Yoon-Koo Kang
Journal:  Gastric Cancer       Date:  2015-08-15       Impact factor: 7.370

10.  Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I.

Authors:  Toshirou Nishida; Masahiko Tsujimoto; Tsuyoshi Takahashi; Seiichi Hirota; Jean-Yves Blay; Mari Wataya-Kaneda
Journal:  J Gastroenterol       Date:  2015-10-29       Impact factor: 7.527
View more
  4 in total

Review 1.  Management of Advanced Small Bowel Cancer.

Authors:  Alberto Puccini; Francesca Battaglin; Heinz-Josef Lenz
Journal:  Curr Treat Options Oncol       Date:  2018-11-05

Review 2.  Asian consensus guidelines for gastrointestinal stromal tumor: what is the same and what is different from global guidelines.

Authors:  Toshirou Nishida
Journal:  Transl Gastroenterol Hepatol       Date:  2018-02-08

3.  Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): a case report.

Authors:  Sergio Carrera; Elena Beristain; Aintzane Sancho; Eluska Iruarrizaga; Pilar Rivero; Juan Manuel Mañe; Guillermo López Vivanco
Journal:  Hered Cancer Clin Pract       Date:  2019-08-09       Impact factor: 2.857

Review 4.  Non-Coding RNAs, a Novel Paradigm for the Management of Gastrointestinal Stromal Tumors.

Authors:  Azadeh Amirnasr; Stefan Sleijfer; Erik A C Wiemer
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.